How is insulin resistance actually tested?
Written and medically reviewed by Zahraa Sater, M.D., M.P.H.
Reviewed August 12, 2026 · Next review due August 12, 2028
Short answer
Insulin resistance has no routine clinical test. The research standard is the hyperinsulinemic euglycemic clamp, which is not available in ordinary practice. NIDDK states that insulin resistance testing is used primarily in research studies. In clinic, insulin resistance is inferred from fasting glucose, HbA1c, an oral glucose tolerance test, triglycerides, HDL cholesterol, liver enzymes and waist measurement.
There is no blood test that diagnoses insulin resistance the way a TSH diagnoses hypothyroidism. NIDDK puts it plainly: health care professionals may not test for insulin resistance, because that testing is "primarily used only for research studies". What clinicians do instead is measure the consequences of insulin resistance and the risk that goes with it.
The test that defines insulin resistance
The reference method for insulin resistance is the hyperinsulinemic euglycemic clamp. Insulin is infused at a fixed rate while glucose is infused at whatever rate keeps blood glucose steady, and the amount of glucose needed measures how sensitive the body is. The clamp takes hours, needs two intravenous lines and continuous bedside sampling, and exists in research units. No commercial lab offers it, and no guideline asks for it before treating anyone.
What gets measured instead
In practice the workup for suspected insulin resistance is a fasting glucose, an HbA1c, and where those are borderline a 75 g oral glucose tolerance test, plus a lipid panel, liver enzymes and a waist measurement. The oral glucose tolerance test is the most sensitive of the three glucose tests for picking up early problems, because it shows what happens after a glucose load rather than only at rest. It is also the least convenient, which is why it is underused outside pregnancy.
| Test | What it shows | Status in practice |
|---|---|---|
| Euglycemic clamp | True insulin sensitivity | Research only |
| Oral glucose tolerance test | Glucose handling after a 75 g load | Diagnostic for prediabetes and diabetes |
| Fasting glucose and HbA1c | Where glycemia has already drifted | Standard first line |
| Fasting insulin, HOMA-IR | Rough estimate of insulin output | No agreed cut-off, not in diagnostic criteria |
Where fasting insulin and HOMA-IR fit
Fasting insulin and HOMA-IR are widely sold in wellness panels as tests for insulin resistance. They are calculations built for population research. The 2026 ADA Standards of Care define prediabetes and diabetes using glucose and A1C only, and neither fasting insulin nor HOMA-IR appears anywhere in those criteria. A high fasting insulin can support a clinical impression. It cannot make a diagnosis, and a normal value does not rule anything out.
A reasonable request at your next visit: fasting glucose, HbA1c, a full lipid panel, ALT and AST, and a two hour oral glucose tolerance test if the first two are borderline. If you have PCOS, a family history of type 2 diabetes, previous gestational diabetes, or fat visible in the liver on imaging, ask for the glucose tolerance test up front rather than waiting for the fasting number to fail.
The clinical detail
The USPSTF gives a B recommendation for screening for prediabetes and type 2 diabetes in adults aged 35 to 70 years who have overweight or obesity, and suggests rescreening every three years when glucose is normal. It advises considering earlier screening in people of American Indian or Alaska Native, Asian American, Black, Hispanic or Latino, or Native Hawaiian or Pacific Islander background, and in those with a family history of diabetes, prior gestational diabetes or polycystic ovary syndrome. The USPSTF notes a lower BMI threshold of 23 or above is reasonable in Asian American adults.
Any diagnostic glucose or A1C abnormality should be confirmed, either by a second test on the same sample or by repeat testing on a separate day, unless the person has unequivocal hyperglycemia with symptoms.
Written and medically reviewed by Zahraa Sater, M.D., M.P.H.
Reviewed August 12, 2026 · Next review due August 12, 2028
Sources
- Insulin Resistance and Prediabetes. National Institute of Diabetes and Digestive and Kidney Diseases
- Screening for Prediabetes and Type 2 Diabetes: Recommendation Statement. US Preventive Services Task Force
- 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes 2026. American Diabetes Association. PMID 41358893
- Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. DOI 10.1007/BF00280883
This library is educational and is not individual medical advice. Read our Editorial and Medical Review Policy.